<%@ include view='MirrorPage' %>
Drug Discovery Today
Transcription Factor
          WEBSITE           DIGITAL EDITION REGISTRATION           EVENTS           CONTACTS                                                          RSS   RSS feed

Drug Discovery Today ENews - June 2020

Editor's Choice

The Current issue of “The view from here” is concerned with Artificial Intelligence and Adverse Drug Reactions The topic of this month’s newsletter from Drug Discovery Today is “Artificial Intelligence and Adverse Drug Reactions”. More


Free Research Articles to Download

Artificial Intelligence in Drug Development: The present status and Future prospects
09 June 2020
The pharma industry is collaborating with AI industries to overcome challenges.

Drug Discovery Chemistry

Deep Learning in Drug Discovery Opportunities, Challenges and Future Prospects
09 June 2020
We review deep learning methods/tools relevant to drug discovery research.

EMBL Chemical Biology

Machine Learning on adverse drug reactions for Pharmacovigilance
09 June 2020
The application of machine learning in pharmacovigilance

Prefilled syringes San Francisco

Drug Induced Liver Injury severity and toxicity (DILIst) Binary classification of 1303 drugs by human hepatotoxicity
09 June 2020
This drug list provides access to the largest number of drugs classified for human hepatotoxicity.


Drug-induced Rhabdomyolysis Atlas (DIRA) for Idiosyncratic Adverse Drug Reaction Management
09 June 2020
A drug-induced rhabdomyolysis (DIR) classification scheme was developed based on drug labeling information.

Inhalation and respiratory

Adverse drug reactions on sexual functioning: a systematic overview
09 June 2020
More than 300 drugs are registered that have sexual adverse drug reactions.

Wearable injectors

For a full list of downloads/ white papers, please visit

Industry News

The Royal Society of Chemistry’s Emerging Technologies Competition 2020 welcomes entries Competition to bring cutting-edge science to the real world seeks projects to tackle the world’s most pressing issues in extraordinary year More

Pharma Micro

India-based Sai Life Sciences sets up first European hub at Alderley Park India-based Sai Life Sciences sets up first European hub at Alderley Park More


New framework to drive widespread adoption of Value-Based Health Care in Europe published EIT Health launches an in-depth framework for adopting and accelerating Value-Based Health Care (VBHC) across Europe. The framework advises how healthcare services can improve patient outcomes and reduce wasted resources. It is published within a new handbook that draws on the experiences of over 240 European VBHC pioneers across 22 countries in Europe, including 32 site visits in leading medical centres. More

December Evolution

Rentschler Biopharma licenses Horizon Discovery’s CHOSOURCE platform to complement cell line development offering for difficult-to-express proteins CHOSOURCE platform to be combined with Rentschler Biopharma’s novel in-house cell line development process to provide speed, stability and high yield More

Injectablle drug delivery

CARTANA launches expanded range of In Situ Sequencing kits for high throughput single cell gene expression mapping Stockholm, May 1st, 2020 – Swedish biotechnology company CARTANA today announced the launch of a new range of In Situ Sequencing (ISS) reagent kits designed to increase the efficiency and enable ISS on virtually any tissue sample. Users will be able to analyse either fresh/fixed frozen or FFPE samples and rapidly create single cell gene expression maps of up to 600 genes. More

Pharma Microbiology


Oligonucleotide Therapeutics and Delivery Conference
Dates: 16 September 2020 until 17 September 2020
Location: Holiday Inn Kensington Forum, London
Website: http://www.oligonucleotide.co.uk/DDTwl

The 18th Annual Congress of International Drug Discovery Science & Technology
Dates: 15 July 2020 until 17 July 2020
Location: tbc Amsterdam, The Netherlands
Website: http://www.iddst.com/iddst2020/

For a full list of events and conferences, please visit

Subscribe to the Digital Edition

This message has been sent to <%= recipient.email %> from Elsevier Communications on behalf of Drug Discovery Today.

If you no longer wish to receive messages of this nature from us in the future, please <%@ include view='UnscubscriptionLink' %>.

Visit the <%@ include view='UnscubscriptionLinkSubscriptionLink' %> to manage your communication preferences with us.

Copyright © 2019 Elsevier B.V.. All rights reserved. | Elsevier Privacy Policy
Elsevier B.V. Registered Office: Radarweg 29, 1043 NX Amsterdam, The Netherlands. Reg. No. 33158992 – Netherlands. VAT No. NL 005033019B01.